Massive Proprietary Biological Dataset: Recursion has generated one of the largest and most comprehensive proprietary biological datasets in the world, consisting of billions of cellular images and associated biological measurements from millions of unique experimental perturbations. This unique data asset is a foundational input for their AI models.

Advanced AI/ML Drug Discovery Platform: The Recursion OS leverages state-of-the-art machine learning and artificial intelligence algorithms to analyze its proprietary biological data, identify novel drug candidates, understand disease mechanisms, and predict therapeutic efficacy with potentially higher success rates than traditional methods.

Industrial-Scale Experimental Automation: Recursion operates highly automated robotic laboratories capable of executing millions of biological experiments per week. This industrialized approach ensures high-quality, standardized, and reproducible data generation at an unprecedented scale, continuously feeding and improving their AI models.